Apollo Hospitals Greams Road reported the treatment of a 67-year-old patient with heart disease using a BASILICA-assisted ...

Apollo Hospitals, Chennai has successfully treated a high-risk 67-year-old patient with complex heart disease using a rare Basilica-assisted Transcatheter Aortic Valve Implantation (TAVI) procedure, ...

Adding a balloon or stent procedure (endovascular angioplasty to widen blood vessels in the neck) to standard treatment may make little to no difference to the chance of another stroke or mini-stroke ...

The FDA approved Endospan's Nexus aortic arch stent graft system, a bimodular device designed to mimic the ascending and arch ...

Boston Scientific has also initiated a recall involving 63 affected units of the Polarx and Polarx FIT Cryoablation Balloon ...

For large vessel occlusion (LVO), mechanical thrombectomy (MT) is the gold standard, extending the treatment window from 4.5 to 24 hours. Using an animal model of ascending pharyngeal artery occlusion ...

LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group"; stock code: ...

MiRus announced that it successfully enrolled and treated the first patients in the STAR trial of its Siegel transcatheter ...

Research suggests that over 120,000 patients suffer from aortic arch disease in the US and Europe annually, but only around ...

Artivion announces Endospan’s NEXUS Aortic Arch System receives US FDA approval: Atlanta Wednesday, April 8, 2026, 14:00 Hrs [IST] Artivion, Inc., a leading cardiac and vascular ...

Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS (R) ...

Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced ...